Literature DB >> 24198061

Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls.

Alison J Dawson1, Thozhukat Sathyapalan, Peter Sedman, Ramzi Ajjan, Eric S Kilpatrick, Stephen L Atkin.   

Abstract

BACKGROUND: Insulin resistance (IR) after bariatric surgery is significantly lower than controls matched for body mass index (BMI) and is indistinguishable from lean subjects however it is not known if this is the same for associated cardiovascular risk (CVR) markers (endothelial function (EF) and clot structure and function (maximum absorbance (MA) lysis potential (LT) and clot formation time (FT).
OBJECTIVE: We sought to determine if IR and associated CVR markers one year after bariatric surgery were comparable to post surgery age and BMI matched controls.
METHODS: Ten patients had before and 12 months after Roux-en-Y surgery CVR measurements compared to controls.
RESULTS: BMI reduced after surgery to 33.3±1.7 kg/m(2) p<0.001 comparable to controls 32.6±1.6 kg/m(2) p=0.87. Fasting glucose reduced after surgery to 4.6±0.1 mmol/L, lower than controls 5.0±0.1 mmol/L p=0.03. IR (calculated using HOMA-IR) reduced 0.77±0.14 p=0.03 and was lower than controls 2.35±0.32 p= 0.02. Systolic blood pressure (BP) reduced to 114.2±3.6 mmHg which was lower than controls 127.7±4.1 mmHg p=0.04, but diastolic BP was unaffected by surgery and no different to controls. EF, hsCRP and HDL-cholesterol improved after surgery and did not differ to controls. Markers of blood clotting: MA and FT were unaffected by surgery and no different to controls, LT improved after surgery 3078±580 to 1665±330s p= 0.04) and was no different to controls (2088±556s p=0.12)
CONCLUSIONS: Bariatric surgery improved cardiovascular risk parameters to that of the equivalent controls post surgery for weight including EF, hsCRP and LT supporting bariatric surgery as an effective management of obesity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24198061     DOI: 10.1007/s11695-013-1100-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  49 in total

1.  Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study.

Authors:  M Wei; S P Gaskill; S M Haffner; M P Stern
Journal:  Obes Res       Date:  1997-01

2.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty.

Authors:  J M Kellum; J F Kuemmerle; T M O'Dorisio; P Rayford; D Martin; K Engle; L Wolf; H J Sugerman
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

3.  Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients.

Authors:  Eva Pardina; Roser Ferrer; Joaquín Rivero; Juan A Baena-Fustegueras; Albert Lecube; Jose M Fort; Víctor Vargas; Roberto Catalán; Julia Peinado-Onsurbe
Journal:  Obesity (Silver Spring)       Date:  2011-12-22       Impact factor: 5.002

Review 4.  Different effects of antihypertensive drugs on endothelial dysfunction.

Authors:  Paolo Puddu; Giovanni Maria Puddu; Eleonora Cravero; Antonio Muscari
Journal:  Acta Cardiol       Date:  2004-10       Impact factor: 1.718

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 6.  Current status of medical and surgical therapy for obesity.

Authors:  E C Mun; G L Blackburn; J B Matthews
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

7.  The effect of gastric bypass surgery on hypertension in morbidly obese patients.

Authors:  J L Carson; M E Ruddy; A E Duff; N J Holmes; R P Cody; R E Brolin
Journal:  Arch Intern Med       Date:  1994-01-24

8.  Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity.

Authors:  J N Primrose; J A Davies; C R Prentice; R Hughes; D Johnston
Journal:  Thromb Haemost       Date:  1992-10-05       Impact factor: 5.249

Review 9.  Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.

Authors:  Anetta Undas; Robert A S Ariëns
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-11       Impact factor: 8.311

Review 10.  Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.

Authors:  Ele Ferrannini; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

View more
  1 in total

1.  Using Integrative Analysis of DNA Methylation and Gene Expression Data in Multiple Tissue Types to Prioritize Candidate Genes for Drug Development in Obesity.

Authors:  Qingjie Guo; Ruonan Zheng; Jiarui Huang; Meng He; Yuhan Wang; Zonghao Guo; Liankun Sun; Peng Chen
Journal:  Front Genet       Date:  2018-12-19       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.